Skip to main content
Northwestern University Feinberg School of Medicine
The Ken & Ruth Davee Department of Neurology

Publications

Below are the 50 most recent publications by faculty members in the Department of Neurology at Northwestern University Feinberg School of Medicine.

  1. Air EL, Ryschon AM, Rosenow JM, Garner AM, Levin RW, Konrad PE, Pietzsch JB  Cost-effectiveness of vagus nerve-mediated neuroimmune modulation for the treatment of moderate-to-severe rheumatoid arthritis.  J Med Econ  2026 Dec;29(1):1462-1473. doi:10.1080/13696998.2026.2662122
  2. Zhang C, Wang R, Capal JK, Srivastava S, Filip-Dhima R, Bebin EM, Krueger DA, Northrup H, Wu JY, Warfield SK  et al.  A two-step temporal data augmentation and supervised learning framework for predicting autism diagnosis at 36 months in patients with tuberous sclerosis complex.  Comput Biol Med  2026 Jul 01;210:111719. doi:10.1016/j.compbiomed.2026.111719
  3. Wolkiewicz L, Okematti E, Ghandour D, Guo K, Gerard EE, Nathan CL  EEG and MRI Correlate of Aphasia in a Patient With Thrombotic Thrombocytopenic Purpura.  Neurology  2026 Jun 23;106(12):e218092. doi:10.1212/WNL.0000000000218092
  4. Li J, Wang X, Tong L, Feng B, Shih LK, Markwell SM, Nuszen H, Gruchala T, Lam NG, Basakis P  et al.  The Peri-necrotic Niche of Glioblastoma Drives Tumor-associated Macrophage Polarization and Immunosuppression via Podoplanin-mediated CLEC5A Activation.  J Clin Invest  2026 Jun 02;. pii:e199228
  5. Li N, Gao Q, Jia H, Xue G, Zhou Y, Wang S, Ma S, Hu B, Zhao Z, Su C  et al.  SIRT2-mediated deacetylation activates USP22 catalytic function for PD-L1 protein stabilization and tumor immune escape.  J Clin Invest  2026 Jun 02;. pii:e198270
  6. Kim M, Reid KJ, Friedlander R, Grobman WA, Wolf MS, Facco F, Silver RM, Greenland P, Yee LM, Zee PC  Initiation of first-generation antihistamines during pregnancy and gestational restless legs syndrome: a secondary analysis of the nuMoM2b cohort.  Am J Obstet Gynecol MFM  2026 Jun;8(6):101940. doi:10.1016/j.ajogmf.2026.101940
  7. Minogue G, Zouridakis A, Nelson C, Kawles A, Keszycki R, Macomber A, Weintraub S, Gill N, Mao Q, Jamshidi P  et al.  Syndrome-specific vulnerability of neuronal and glial 4-repeat frontotemporal lobar degeneration-tau.  Brain  2026 Jun 01;. pii:awag190
  8. Menozzi E, Toffoli M, Deleidi M, Di Monte DA, Blandini F, Krainc D, Sidransky E, Schapira AHV  New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment.  Lancet Neurol  2026 Jun;25(6):602-614. doi:10.1016/S1474-4422(26)00090-6
  9. Dalal V, Zhou Y, Deb DK, Thomson BR, Nelson JW, Ledogar G, Misener S, Maekawa H, Chang A, Chung E  et al.  Transcription factor 21 deletion from podocyte precursors as a model for congenital nephrotic syndrome.  Am J Physiol Renal Physiol  2026 Jun 01;330(6):F746-F760. doi:10.1152/ajprenal.00490.2025
  10. Mencacci NE, Minakaki G, Maroofian R, De Pace R, Paimboeuf A, Branco Fonseca T, Abramova T, Shannon P, Chitayat D, Magrinelli F  et al.  Pathogenic variants in BORCS5 cause a spectrum of neurodevelopmental and neurodegenerative disorders with lysosomal dysfunction.  J Clin Invest  2026 Jun 01;136(11). pii:e195336
  11. Queisi MM, Tomatsu S, Jacobs Z, Dada M, Wuppalapati SN, Posada F, Weller J, Wilken J, Hancock L, Penner I  et al.  Depression severity and discordance between fatigue patient-reported outcomes in people with multiple sclerosis.  Mult Scler Relat Disord  2026 Jun;110:107192. doi:10.1016/j.msard.2026.107192
  12. Sorenson E, Heitzman D, Lee I, Jang G, Elman L, Habib AA, Wymer J, Hayat G, Goutman SA, Fernandes JAM  et al.  Prospective Validation of the New PLS Diagnostic Criteria From PLS Natural History Study: EMG and Neurofilament Analyses.  Muscle Nerve  2026 Jun;73(6):976-983. doi:10.1002/mus.70192
  13. Gregori G, Sahoo NK, Hasan N, Zarnegar A, Lupidi M, Zhang M, Wu L, Cao J, Piccoli G, Vujosevic S  et al.  Demography, Clinical Characteristics and Long-Term Outcomes of Central Serous Chorioretinopathy in Women. MICRoN Report Number Fourteen.  Am J Ophthalmol  2026 Jun;286:140-151. doi:10.1016/j.ajo.2026.02.039
  14. Sahoo NK, Hasan N, Jacob N, Cao J, Wykoff CC, Shah P, Singhanetr P, Rossin EJ, Desideri LF, Hertkorn F  et al.  Clinical Characteristics and Outcomes in Central Serous Chorioretinopathy With Subretinal Hyper-Reflective Material: MICRoN Report 6.  Am J Ophthalmol  2026 Jun;286:152-162. doi:10.1016/j.ajo.2026.02.037
  15. Sharma R, Tiwari R, Zhou Y, O'Sullivan J, Maekawa H, Borkowski GS, Bukaric H, An SY, Thorp EB, Chandel NS  et al.  Endothelial prolyl hydroxylase 3 mitigates maladaptive inflammation to promote post-ischemic kidney repair.  Kidney Int  2026 Jun;109(6):1173-1187. doi:10.1016/j.kint.2026.01.017
  16. Maas MB  Abnormal sleep during acute illness: Therapeutic opportunity or allostatic phenomenon.  J Hosp Med  2026 Jun;21(6):687-688. doi:10.1002/jhm.70246
  17. Sadagopan NS, Jain R, Chaliparambil RK, Khazanchi R, Rosenow JM, Potts MB, Chandler JP, Tate MC, Magill ST, Geynisman-Tan J  Sex Disparities in Normal Pressure Hydrocephalus Diagnosis and Urinary Outcomes.  Urogynecology (Phila)  2026 Jun 01;32(6):761-768. doi:10.1097/SPV.0000000000001737
  18. Nikolcheva T, Pagano G, Anzures-Cabrera J, Trundell D, Kustermann T, Simuni T, Marek K, Pavese N, Seppi K, Stocchi F  et al.  Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study.  Lancet  2026 May 30;407(10544):2227-2240. doi:10.1016/S0140-6736(26)00865-2
  19. Eldabe S, Nevitt S, Hunter CW, Rosenow JM, Maden M, Goudman L, Moens M, Kalia H, Soliday N, Leitner A  et al.  Response to: "Methodological limitations and conflicts of interest in spinal cord stimulation research impair trustworthiness".  Reg Anesth Pain Med  2026 May 29;. pii:rapm-2026-108122
  20. Vincze K, Szwajda A, Ploner A, Karlsson R, Kang X, Tang B, Qin C, Domenighetti C, Sugier PE, Ashok Kumar Sreelatha A  et al.  Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onset.  NPJ Parkinsons Dis  2026 May 28;12(1). pii:127
  21. Piña Y, Umeh Garcia M, Boire A, Brenner A, Camidge DR, Chang S, Forsyth PA, Hayden Gephart M, Olayinka Kamson D, Kumthekar P  et al.  Breaking Barriers in Leptomeningeal Disease: A SNO-ASCO Consensus Review on Clinical Trial Design and Basic Science Integration.  Neuro Oncol  2026 May 27;. pii:noag126
  22. Lukas RV, Zhai L, Lauing KL, Kim M, Koch T, Penco-Campillo M, Bommi P, Dixit K, Kumthekar P, Sharp L  et al.  Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205.  Clin Cancer Res  2026 May 26;. doi:10.1158/1078-0432.CCR-26-1124
  23. Khani M, Yeboah SN, Cerquera-Cleves C, Kedmi A, Bustos BI, Grant SM, Can Akerman S, Akçimen F, Lee PS, Reyes-Pérez P  et al.  Is SORL1 a common genetic target across neurodegenerative diseases? A multi-ancestry biobank study.  Brain  2026 May 26;. pii:awag187
  24. Chung PA, Fleming VL, Reid KJ, Plante DT, Hom CL, Ances BM, Handen BL, Christian BT, Head E, Mapstone M  et al.  Circadian Rest-Activity Rhythms, Cognition, and Alzheimer Disease Dementia in Adults With Down Syndrome.  Neurology  2026 May 26;106(10):e214938. doi:10.1212/WNL.0000000000214938
  25. Hwang J, Cho SM, Johnson EL, Kimchi EY, Schuele SU, Habela CW, Ritzl EK  Typical and Atypical Frequency-Based Subtypes of EEG Reactivity in Hospitalized Patients and Association With Comorbidities and Outcomes.  Neurology  2026 May 26;106(10):e218034. doi:10.1212/WNL.0000000000218034
  26. Hasan N, Sahoo N, Gidwani K, Saju S, Cao J, Wykoff CC, Shah P, Singhanetr P, Rossin E, Ashfaq Y  et al.  Predictors of Good Visual Recovery in Patients with Spontaneously Resolved Acute CSCR - MICRoN Report Number Thirteen.  Am J Ophthalmol  2026 May 20;. pii:S0002-9394(26)00257-6
  27. Mueller A, Vallejo V, Panadés MP, Hardiman O, Danel-Brunaud V, Ajroud-Driss S, Couratier P, Shefner J, Gokey A, DiCesare M  et al.  Evaluation of Digital Technologies for Home-Based Assessment in People With Amyotrophic Lateral Sclerosis.  Ann Clin Transl Neurol  2026 May 20;. doi:10.1002/acn3.70429
  28. Koerner J, Zou E, Karl JA, Poon C, Malkani RG, Verhagen Metman L, Sodini CG, Sze V, Heldt T, David FJ  iPad Eye Tracking Reproduces Clinical Grade Oculomotor Differences in Parkinson's Disease.  NPJ Digit Med  2026 May 19;. doi:10.1038/s41746-026-02753-9
  29. Gonzalez-Latapi P, Gochanour C, Choi SH, Cho H, Caspell-Garcia C, Coffey CS, Lafontant DE, Xiao Y, Tanner CM, Venuto CS  et al.  Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative.  Ann Neurol  2026 May 18;. doi:10.1002/ana.78248
  30. Zhang Z, van Olst L, Alessandrini F, Wright M, Edwards AJ, Boles J, Nalbandian A, Forsyth AV, Shepard N, Watson T  et al.  Integrated single-cell and spatial transcriptomic profiling in ALS uncovers peripheral-to-central immune infiltration and reprogramming.  Nat Neurosci  2026 May 14;. doi:10.1038/s41593-026-02300-5
  31. Kang X, Lin Z, Calikusu FZ, Miller LA, Soriano S, Locascio JJ, Corvol JC, Maple-Grødem J, Fan Y, Mead K  et al.  Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohorts.  NPJ Parkinsons Dis  2026 May 14;. doi:10.1038/s41531-026-01367-y
  32. Brown EG, Chahine LM, Dobkin RD, Simuni T, Foroud T, Heathers LEA, Tropea TF, Stanley CE, McMahon BA, Brüggemann N  et al.  Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative.  Ann Neurol  2026 May 14;. doi:10.1002/ana.78246
  33. Quiring ML, Edwards L, Bangen KJ, Ho EH, Carlsson CM, Galasko D, Weintraub S, Gershon R, Salmon DP  Effects of age and APOE ϵ4 genotype on the relationship between pulse pressure and executive function in older adults without Dementia.  J Int Neuropsychol Soc  2026 May 13;:1-10. doi:10.1017/S1355617726102008
  34. Siderowf A, Heathers LEA, Fabrizio K, Kuhl MM, Kopil CM, Flagg E, McMahon BA, Coffey CS, Bright A, Totten M  et al.  Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease.  Ann Neurol  2026 May 10;. doi:10.1002/ana.78239
  35. Tanner CM, Stanley CE, Brown EG, Chahine LM, Weintraub D, Dobkin RD, Poewe W, Tolosa E, Marras C, Schade S  et al.  Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI.  Ann Neurol  2026 May 10;. doi:10.1002/ana.78245
  36. Simuni T, Coffey CS, Kopil CM, Allen-Savietta C, Wendelberger B, Crawford A, Schneider RB, Siderowf A, Kieburtz K, Tanner CM  et al.  How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early-Stage Neuronal Alpha-Synuclein Disease.  Ann Neurol  2026 May 07;. doi:10.1002/ana.78250
  37. Bieber D, Abdallah RT, Ab-Elsayed A, Burkey AR, Englot DJ, Gupta K, Munyon CN, Halpern CH, Miller KJ, Rosenow JM  et al.  Development of an Educational Curriculum for the Surgical Implantation of DBS Systems.  Neuromodulation  2026 May 06;. pii:S1094-7159(26)00112-1
  38. Lee JY, Park SH, Lee K, Lee SJ, Kang K, Cha JK, Guk HS, Kim N, Kim J, Kim DY  et al.  Real-world effectiveness of thrombectomy for basilar artery occlusion: lessons beyond the ATTENTION and BAOCHE trials.  Eur Stroke J  2026 May 06;11(5). pii:aakag031
  39. Chahine LM, Alcalay RN, Brown EG, Chowdhury S, Coffey CS, Foroud T, Frasier M, Galasko D, Merchant KM, Mollenhauer B  et al.  Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers Initiative.  Ann Neurol  2026 May 06;. doi:10.1002/ana.78249
  40. Yadav S, Hasan N, Sahoo N, Zarnegar A, Cao J, Zhou A, Saju S, Wykoff CC, Shah P, Singhanetr P  et al.  Comparison between thin and thick choroid eyes in central serous chorioretinopathy.  Retina  2026 May 05;. doi:10.1097/IAE.0000000000004875
  41. Mukund K, Thompson SD, Rugel CL, Gebis KK, Lieber RL, Savas JN, Subramaniam S, Lavasani M  Single-cell transcriptional landscape of muscle-derived stem/progenitor cells reveals hallmarks of aging and rejuvenation.  bioRxiv  2026 May 01;. pii:2026.04.28.721405
  42. Yan X, Fang Z, Ang KS, Olst LV, Edwards A, Watson T, Zheng R, Zhang D, Fan R, Li M  et al.  Mosaic integration of spatial multi-omics with SpaMosaic.  Nat Genet  2026 May;58(5):1126-1137. doi:10.1038/s41588-026-02573-3
  43. Yu X, Song X, Schäfer RA, Meng Q, Tiek D, Wu R, He Q, Walker M, Cao Q, Yang R  et al.  An EGFR co-amplified lncRNA HELDR promotes glioblastoma malignancy through KAT7-driven gene programs.  Nat Cell Biol  2026 May;28(5):972-985. doi:10.1038/s41556-026-01924-w
  44. Wang H, Walenski M, Litcofsky K, Mack JE, Mesulam MM, Thompson CK  Online comprehension of verbal time reference in primary progressive aphasia: Evidence from eyetracking.  J Neurolinguistics  2026 May;78. pii:101318
  45. Vecchio A, Cohen-Zimerman S, Grafman J  Exploring the brain basis of self-monitoring.  Cortex  2026 May;198:1-12. doi:10.1016/j.cortex.2026.02.011
  46. Wu R, Yu X, Song X, He Q, Walker M, Sisbarro D, Horbinski C, Tiek D, Hu B, Zhang N  et al.  Tumor-associated astrocytes augment cholesterol synthesis to support glioblastoma growth through alternatively spliced QKI isoforms.  Neuro Oncol  2026 May 01;28(5):1163-1178. doi:10.1093/neuonc/noag030
  47. Rajan A, Castro FR, de Godoy LL, Hanaoka M, Turk S, Desiderio L, Stupp R, Mohan S, Chawla S  Imaging biomarkers for detecting IDH mutations and monitoring response to novel targeted therapies: Current insights and future perspectives.  Neuro Oncol  2026 May 01;28(5):1101-1116. doi:10.1093/neuonc/noag028
  48. Hanin A, Marois C, Guillemaud M, Chavez M, Cosme L, Hayatou Z, Besnard A, Goudard G, Masson V, Cousyn L  et al.  Exploring pathways leading to drug-resistant epilepsy for patients with cryptogenic new onset refractory status epilepticus.  Epilepsia  2026 May;67(5):2326-2346. doi:10.1002/epi.70146
  49. Arends S, de Koning L, Drenthen J, Zhu M, van den Bergh PYK, Hadden RM, Shahrizaila N, Reisin RC, Kuwabara S, Ajroud-Driss S  et al.  Dynamics of Nerve Conduction Studies in Patients With Guillain-Barré Syndrome.  Muscle Nerve  2026 May;73(5):832-842. doi:10.1002/mus.70152
  50. Brooker SM, Pasquini J, Choi SH, Lafontant DE, Fereshtehnejad SM, Zeighami Y, Grillo P, Riboldi GM, Azizi H, Moqadam R  et al.  Clinical and Imaging Characteristics of Parkinson's Disease with Negative Alpha-Synuclein Seed Amplification Assay.  Mov Disord  2026 May;41(5):1114-1127. doi:10.1002/mds.70197

Follow Neurology on InstagramFacebookLinkedIn